Robert Hoffman

Robert Hoffman

Directeur Général chez CYTODYN INC.

Fortune : 7 376 $ au 31/10/2026

60 ans
Health Technology
Technology Services
Health Services

Profil

Robert E.
Hoffman
is Director at Day For Change.
Director at TuHURA Biosciences, Inc. since 2024.
Independent Director at FibroBiologics, Inc. starting 2025.
Chief Executive, Financial & Accounting Officer at CytoDyn, Inc. starting 2026.
Formerly Chairman, President, Chief Executive Officer & CFO at Kintara Therapeutics, Inc. from 2023 to 2024.
Chairman at Antibe Therapeutics, Inc. from 2022 to 2024.
Director at Telik, Inc. Independent Director at CombiMatrix Corp.
from 2013 to 2017.
Director at Zeta Acquisition Corp.
III.
Independent Director at Kura Oncology, Inc. from 2015 to 2021.
Independent Non-Executive Director at Aslan Pharmaceuticals Ltd. Independent Director at Versartis, Inc. President & Director at Financial Executives International of San Diego Chapter from 2010 to 2020.
Independent Director at Saniona AB from 2021 to 2022.
Independent Director at MabVax Therapeutics Holdings, Inc. from 2014 to 2017.
Independent Director at Aravive, Inc. from 2018 to 2020.
Independent Director at ASLAN Pharmaceuticals Pte Ltd. Independent Director at Esperion Therapeutics, Inc. from 2025 to 2026.
Chief Financial Officer & Senior VP-Finance at Heron Therapeutics, Inc. from 2017 to 2020.
Assistant Controller at Document Sciences Corp.
from 1994 to 1997.
Chief Financial Officer & Senior VP-Finance at Arena Pharmaceuticals, Inc. from 2012 to 2015.
Chief Financial Officer at AnaptysBio, Inc. from 2015 to 2016.
Chief Financial & Accounting Officer, Executive VP at Innovus Pharmaceuticals, Inc. from 2016 to 2017.
Chief Financial Officer at Polaris Group, Inc. in 2011.
Chief Financial Officer & Senior VP-Finance at Arena Pharmaceuticals, Inc. Education includes an undergraduate degree from St. Bonaventure University conferred in 1988.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
0,01 %
26/06/2026 3 641 ( 0,01 % ) 7 027 $ 31/10/2026
20/07/2026 375 ( 0,01 % ) 349 $ 31/10/2026

Postes actifs de Robert Hoffman

SociétésPosteDébut
CYTODYN INC. Directeur Général 20/10/2026
FIBROBIOLOGICS, INC. Directeur/Membre du Conseil 08/04/2021
Directeur/Membre du Conseil -

Anciens postes connus de Robert Hoffman

SociétésPosteFin
ESPERION THERAPEUTICS, INC. Directeur/Membre du Conseil 13/07/2026
KINTARA THERAPEUTICS, INC. Directeur Général 01/10/2024
Directeur/Membre du Conseil 17/07/2024
ANTIBE THERAPEUTICS INC. Président 24/04/2024
SANA AB Directeur/Membre du Conseil 25/05/2022
Voir l'expérience en détail de Robert Hoffman

Formation de Robert Hoffman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Robert Hoffman
🔇